Octagon Capital Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-624,500
Closed -$38.7M 44
2022
Q3
$38.7M Buy
624,500
+294,500
+89% +$18.2M 6.67% 4
2022
Q2
$26.3M Buy
330,000
+230,000
+230% +$18.3M 7.02% 4
2022
Q1
$10.5M Buy
+100,000
New +$10.5M 2.27% 14